Factors Associated With Sacubitril/Valsartan Continuation and the Methods of Combining Heart Failure Medications in Patients With Heart Failure.

Erika Iwasaki Noriko KohyamaMayumi InamotoMichiru NagaoTomiko SunagaHiroshi SuzukiMio EbatoMari Kogo

Published in: The Annals of pharmacotherapy (2024)

Albumin, BMI, and SBP are useful indicators for selecting patients who are likely to continue SV. In addition, initiating only SV without simultaneously initiating other HF medications in patients with HFrEF may lead to SV continuation.

Keyphrases

heart failure
ejection fraction
end stage renal disease
newly diagnosed
chronic kidney disease
body mass index
peritoneal dialysis
physical activity